Management of colon cancer: resource-stratified guidelines from the Asian Oncology Summit 2012
- PMID: 23117002
- DOI: 10.1016/S1470-2045(12)70424-2
Management of colon cancer: resource-stratified guidelines from the Asian Oncology Summit 2012
Abstract
Colon cancer is seen with increasing frequency in the Asia-Pacific region, and it is one of the most important causes of cancer mortality worldwide. This article reviews the available evidence for optimum management of colon cancer-in particular, with respect to screening and early detection of colon cancer, laparoscopic surgical treatment, adjuvant treatment of individuals with high-risk stage II and stage III cancer, palliative treatment of patients with metastatic disease, and management of resectable and potentially resectable metastases-and how these strategies can be applied in Asian countries with different levels of health-care resources and economic development, stratified by basic, limited, enhanced, and maximum resource levels.
Copyright © 2012 Elsevier Ltd. All rights reserved.
Similar articles
-
Management of kidney cancer in Asia: resource-stratified guidelines from the Asian Oncology Summit 2012.Lancet Oncol. 2012 Nov;13(11):e482-91. doi: 10.1016/S1470-2045(12)70433-3. Lancet Oncol. 2012. PMID: 23117003 Review.
-
Comparison of Western and Asian Guidelines Concerning the Management of Colon Cancer.Dis Colon Rectum. 2018 Feb;61(2):250-259. doi: 10.1097/DCR.0000000000001012. Dis Colon Rectum. 2018. PMID: 29337781 Review.
-
Management of endometrial cancer in Asia: consensus statement from the Asian Oncology Summit 2009.Lancet Oncol. 2009 Nov;10(11):1119-27. doi: 10.1016/S1470-2045(09)70290-6. Lancet Oncol. 2009. PMID: 19880066 Review.
-
Supportive, palliative, and end-of-life care for patients with cancer in Asia: resource-stratified guidelines from the Asian Oncology Summit 2012.Lancet Oncol. 2012 Nov;13(11):e492-500. doi: 10.1016/S1470-2045(12)70380-7. Lancet Oncol. 2012. PMID: 23117004 Review.
-
Management of HER2-positive breast cancer in Asia: consensus statement from the Asian Oncology Summit 2009.Lancet Oncol. 2009 Nov;10(11):1077-85. doi: 10.1016/S1470-2045(09)70230-X. Lancet Oncol. 2009. PMID: 19880061 Review.
Cited by
-
Radiomics in Oncological PET/CT: Clinical Applications.Nucl Med Mol Imaging. 2018 Jun;52(3):170-189. doi: 10.1007/s13139-017-0500-y. Epub 2017 Oct 20. Nucl Med Mol Imaging. 2018. PMID: 29942396 Free PMC article. Review.
-
Efficacy and Safety of Regorafenib Monotherapy among Patients with Previously Treated Metastatic Colorectal Cancer in a Chinese Population: A Real-World Exploratory Study.Int J Gen Med. 2021 Sep 7;14:5363-5373. doi: 10.2147/IJGM.S325545. eCollection 2021. Int J Gen Med. 2021. PMID: 34522132 Free PMC article.
-
Current Options for the Diagnosis, Staging and Therapeutic Management of Colorectal Cancer.Gastrointest Tumors. 2013 Sep;1(1):25-32. doi: 10.1159/000354995. Epub 2013 Sep 12. Gastrointest Tumors. 2013. PMID: 26674429 Free PMC article. Review.
-
Pro-protein convertase subtilisin/kexin type 9 promotes intestinal tumor development by activating Janus kinase 2/signal transducer and activator of transcription 3/SOCS3 signaling in ApcMin/+ mice.Int J Immunopathol Pharmacol. 2021 Jan-Dec;35:20587384211038345. doi: 10.1177/20587384211038345. Int J Immunopathol Pharmacol. 2021. PMID: 34586888 Free PMC article.
-
Feasibility and Tolerability of Anlotinib Plus PD-1 Blockades for Patients with Treatment-Refractory Metastatic Colorectal Cancer: A Retrospective Exploratory Study.Cancer Manag Res. 2024 Feb 1;16:73-86. doi: 10.2147/CMAR.S427680. eCollection 2024. Cancer Manag Res. 2024. PMID: 38318097 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources